Asha Ramdas
Senior VP
A senior leader in the pharmaceutical industry
with over seventeen years of experience in
product and drug delivery technology
development, regulatory strategy and program
management. Broad experience with small
molecules, peptides and vaccines.

Proven leader with strong collaborative,
cross-functional, inter-company and global team
building skills, with a record of delivery of
significant business results for early and
late-stage programs. Demonstrated ability in
developing and implementing innovative
strategies that integrate design, IP,
manufacturing, regulatory, clinical, and
marketing requirements.

Experience with successful FDA interactions
relating to both CMC and clinical aspects of drug
development. Versatile executive with proven
expertise in defining and setting up critical
business infrastructure. Outstanding leadership
and general management capabilities, effective
in fast-paced startup and large pharma
environments.
Sung-Yun Kwon, Ph.D.
CTO and Founder
Kumar Shah, MS, MBA
Board Member
Gary Pitts, J.D., Ph.D.
Scientific Advisory Board
Luke P. Lee, Ph.D.
Scientific Advisory Board
Casey McGlynn, J.D.
Corporate Counsel
Frank Cano, Ph.D.
CEO